Mannkind (MNKD) Free Cash Flow Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 60.84% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 88.70% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -15.72% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 66.37% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 3.98% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 137.65% |
| 10 | Mannkind | 1.09 Bn | 956.66 Mn | 82.66 Mn | 16.03% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 16.03% |
| Dec 31, 2025 | -153.70% |
| Sep 30, 2025 | 83.46% |
| Jun 30, 2025 | 6,427.50% |
| Mar 31, 2025 | -233.18% |
| Dec 31, 2024 | -35.77% |
| Sep 30, 2024 | -57.82% |
| Jun 30, 2024 | 100.60% |
| Mar 31, 2024 | 492.82% |
| Dec 31, 2023 | 363.44% |
| Sep 30, 2023 | 214.92% |
| Jun 30, 2023 | 30.88% |
| Mar 31, 2023 | 94.50% |
| Dec 31, 2022 | -16.32% |
| Sep 30, 2022 | -34.56% |
| Jun 30, 2022 | -34.61% |
| Mar 31, 2022 | -70.02% |
| Dec 31, 2021 | -2,699.62% |
| Sep 30, 2021 | -50.60% |
| Jun 30, 2021 | -447.93% |
| Mar 31, 2021 | -21.83% |
| Dec 31, 2020 | 96.49% |
| Sep 30, 2020 | 73.84% |
| Jun 30, 2020 | 80.48% |
| Mar 31, 2020 | 5.18% |
| Dec 31, 2019 | -129.89% |
| Sep 30, 2019 | -269.74% |
| Jun 30, 2019 | 25.42% |
| Mar 31, 2019 | 45.19% |
| Dec 31, 2018 | 183.35% |
| Sep 30, 2018 | 40.18% |
| Jun 30, 2018 | -35.52% |
| Mar 31, 2018 | -354.50% |
| Dec 31, 2017 | -135.11% |
| Sep 30, 2017 | -0.86% |
| Jun 30, 2017 | -74.07% |
| Mar 31, 2017 | 126.67% |
| Dec 31, 2016 | 44.23% |
| Sep 30, 2016 | -9.22% |
| Jun 30, 2016 | 48.49% |
| Mar 31, 2016 | -2,596.70% |
| Dec 31, 2015 | 43.83% |
| Sep 30, 2015 | -123.27% |
| Jun 30, 2015 | 29.46% |
| Mar 31, 2015 | 96.92% |
| Dec 31, 2014 | -1.22% |
| Sep 30, 2014 | 373.90% |
| Jun 30, 2014 | -6.02% |
| Mar 31, 2014 | -14.67% |
| Dec 31, 2013 | -42.80% |
| Sep 30, 2013 | 3.61% |
| Jun 30, 2013 | -18.82% |
| Mar 31, 2013 | -2.06% |
| Dec 31, 2012 | -37.31% |
| Sep 30, 2012 | 6.13% |
| Jun 30, 2012 | 38.46% |
| Mar 31, 2012 | -0.34% |
| Dec 31, 2011 | 52.20% |
| Sep 30, 2011 | -0.62% |